| Literature DB >> 35751189 |
Sana Zahid1, Mehreen Gul1, Shagufta Shafique1, Sajid Rashid2.
Abstract
Homologous to E6AP carboxyl-terminus (HECT)-type E3 ligase performs ubiquitin (Ub)-proteasomal protein degradation via forming a complex with E2∼Ub. Enveloped viruses including SARS-CoV-2 escape from the infected cells by harnessing the E-class vacuolar protein-sorting (ESCRT) machinery and mimic the cellular system through PPAY motif-based linking to HECT Ub ligase activity. In the present study, we have characterized the binding pattern of E2UbcH5B to HECT domains of NEDD4L, WWP1, WWP2, HECW1, and HECW2 through in silico analysis to isolate the E2UbcH5B-specific peptide inhibitors that may target SARS-CoV-2 viral egression. Molecular dynamics analysis revealed more opening of E2UbcH5B-binding pocket upon binding to HECTNEDD4L, HECTWWP1, HECTWWP2, HECTHECW1, and HECTHECW2. We observed similar binding pattern for E2UbcH5B and mentioned HECT domains as previously reported for HECTNEDD4L where Trp762, Trp709, and Trp657 residues of HECTNEDD4L, HECTWWP1, and HECTWWP2 are involved in making contacts with Ser94 residue of E2UbcH5B. Similarly, corresponding to HECTNEDD4L Tyr756 residue, HECTWWP1, HECTWWP2, HECTHECW1, and HECTHECW2-specific Phe703, Phe651, Phe1387, and Phe1353 residues execute interaction with E2UbcH5B. Our analysis suggests that corresponding to Cys942 of HECTNEDD4L, Cys890, Cys838, Cys1574, and Cys1540 residues of HECTWWP1, HECTWWP2, HECTHECW1, and HECTHECW2, respectively are involved in E2-to-E3 Ub transfer. Furthermore, MM-PBSA free energy calculations revealed favorable energy values for E2UbcH5B-HECT complexes along with the individual residue contributions. Subsequently, two E2UbcH5B-derived peptides (His55-Phe69 and Asn81-Ala96) were tested for their binding abilities against HECT domains of NEDD4L, WWP1, WWP2, HECW1, and HECW2. Their binding was validated through substitution of Phe62, Pro65, Ile84, and Cys85 residues into Ala, which revealed an impaired binding, suggesting that the proposed peptide ligands may selectively target E2-HECT binding and Ub-transfer. Collectively, we propose that peptide-driven blocking of E2-to-HECT Ub loading may limit SARS-CoV-2 egression and spread in the host cells.Entities:
Keywords: Molecular dynamics; Peptide-driven blockage; SARS-CoV-2; Viral egression
Mesh:
Substances:
Year: 2022 PMID: 35751189 PMCID: PMC9124161 DOI: 10.1016/j.compbiomed.2022.105660
Source DB: PubMed Journal: Comput Biol Med ISSN: 0010-4825 Impact factor: 6.698
Fig. 1Multiple sequence alignment analysis for HECT family members. (A) CTD sequence alignment for HECT family members through ClustalW. The arrows depict conserved residues in reference to HECTNEDD4L that are involved in E2 binding. The numbering can be referred to UniProtKB. (B) 3D structures of HECT family members that are depicted in surface view along with conserved residues labeled in black color. NEDD4L, WWP1, WWP2, HECW1, and HECW2 are represented in yellow, pink, orange, green, and purple colors, respectively.
Interaction analysis for E2UbcH5B and HECT E3s.
| Complex | Hydrogen bonds between E2 and HECT E3s | E2-specific hydrophobic interactions | HECT-specific hydrophobic interactions | Binding Energy (kcal/mol) |
|---|---|---|---|---|
| E2-NEDD4L | Leu3:Gln787 | Ala2, Lys4, Arg5, Phe31, Thr58, Asp59, Pro64, Asn79, Ser83, Arg90, Pro95, Ala96, Asp116, Pro121 | Tyr756, Leu760, Trp762, Leu771, Met774, Asp778, Glu780, Tyr807, Asn871, Glu928, Trp930, Ser942, Phe943 | PDB ID: |
| Lys8:Asp772 | ||||
| Phe62:Ser759 | ||||
| Lys63:Asp753 | ||||
| Lys63:Glu755 | ||||
| Pro118:His940 | ||||
| Leu119:Arg945 | ||||
| E2-WWP1 | Thr58:Glu729 | Met1, Phe31, Pro57, Asp59, Phe62, Lys63, Pro64, Pro65, Lys66, Arg90, Ser91, Gln92, Trp93, Ser94, Pro95, Ala96, Pro121 | Asp700, Thr701, Glu702, Asn705, Ser706, Trp709, Gly719, Leu720, Met722, Ser725, Val726, Asp727, Met728, Val734, Arg767, Cys890, Phe891 | −22.60 |
| Pro118:Arg819 | ||||
| E2-WWP2 | Thr58:Asp675 | Met1, His55, Phe56, Pro57, Asp59, Lys63, Pro64, Pro65, Val67, Ala68, Asn79, Asn81, Gly82, Ser83, Asp87, Arg90, Gln92, Trp93, Ser94, Pro95, Asp116, Asp117, Pro121 | Pro574, Gly583, Lys584, Asn585, Gln590, Ile597, Pro649, Phe651, Trp657, Cys666, Gly667, Leu668, Glu669, Leu670, Ile673, Gln674, Met676, Leu679, Val682, Thr684, Tyr704, Asn816 | −22.56 |
| Phe62:Ser654 | ||||
| Lys66:Glu677 | ||||
| Ser91:Ala582 | ||||
| Ser91:Ile647 | ||||
| Ser91:Asp648 | ||||
| Ser91:Glu650 | ||||
| E2-HECW1 | Met1:Thr1408 | Ala2, Leu3, Asp29, Phe31, Asp59, Phe62, Lys63, Pro64, Val67, Asn79, Ile84, Cys85, Arg90, Trp93, Pro95, Asp116, Asp117, Pro118, Leu119, Val120, Pro121 | Asp1384, Glu1386, Phe1387, Ser1390, Met1394, Leu1403, Leu1405, Thr1406, Val1409, Glu1411, Val1417, Tyr1439, Met1443, Gly1503, Asn1552, Glu1560, Lys1561, Trp1562, Arg1570, Thr1573, Cys1574, Phe1575, Arg1577 | −31.56 |
| Lys4:Glu1419 | ||||
| Thr58:Glu1412 | ||||
| Lys66:Ser1551 | ||||
| Asn81:Arg1555 | ||||
| Ser83:Arg1555 | ||||
| E2-HECW2 | Asp29:Glu1358 | Met1, Phe31, Val49, Phe51, Ile54, His55, Asp59, Pro64, Val67, Ala68, Thr70, Thr71, Asp87, Leu89, Ser91, Pro95, Val126, Tyr145 and Ala146 | Phe1353, Trp1359, Asp1362, Ile1368, Leu1371, Trp1528, Leu1534, Ala1537, Thr1539, Phe1541, Glu1565, Thr1566, Leu1571 | −30.27 |
| His32:Gln1355 | ||||
| Thr53:Ser1356 | ||||
| Thr58:Ser1567 | ||||
| Thr58:Thr1568 | ||||
| Phe62:Arg1536 | ||||
| Lys63:Phe1499 | ||||
| Lys66:Glu1351 | ||||
| Arg72:Leu1369 | ||||
| Arg72:Asp1370 | ||||
| Asn81:Arg1413 | ||||
| Ser83:Glu1352 | ||||
| Arg90:Ser1517 | ||||
| Arg90:Asn1518 | ||||
| Arg90:His1538 | ||||
| Trp93:Arg1536 | ||||
| Met147:Asp1367 |
Fig. 2Binding mode analysis for E2 and HECT domains of NEDD4L, WWP1, WWP2, HECW1, and HECW2. Optimal docked complexes of (A) E2-WWP1, (B) E2-WWP2, (C) E2-NEDD4L, (D) E2-HECW1, and (E) E2-HECW2. E2 is shown in cyan colored ribbon, while the interacting residues are indicated in dark blue sticks. NEDD4L, WWP1, WWP2, HECW1, and HECW2 structures are shown in yellow, pink, orange, green and purple ribbons, respectively, while their respective interacting residues are represented in the ball and stick mode. The interacting residues of E2 and HECTs are labeled in blue and black color, respectively.
Fig. 3Plots to investigate the stability, fluctuations, hydrogen bond, and potential energy for apo-E2 and E2-bound NEDD4L, WWP1, WWP2, HECW1 and HECW2. (A) RMSD plotted as a time function. (B) Comparative RMSF plots for apo-E2 and E2-bound forms of NEDD4L, WWP1, WWP2, HECW1 and HECW2. (C) Comparative analysis of the most fluctuating residues is illustrated by bar chart. (D) Intermolecular hydrogen bonding pattern plot. (E) Potential energy plots of E2-HECT complexes. Apo-E2, E2-NEDD4L, E2-WWP1, E2-WWP2, E2-HECW1, and E2-HECW2 are represented in blue, yellow, pink, orange, green, and purple colors, respectively.
Fig. 42D motion projections for apo-E2 and E2-bound HECT complexes over the first two principal components. (A) Apo-E2, (B) E2-NEDD4L, (C) E2-WWP1, (D) E2-WWP2, (E) E2-HECW1, and (F) E2-HECW2.
Energy contributions (kJ/mol) of E2UbcH5B in complex with NEDD4L, WWP1, WWP2, HECW1, and HECW2.
| Δ | |||||
|---|---|---|---|---|---|
| −390.424±43.284 kJ/mol | −3551.783±256.085 kJ/mol | 1495.262±167.467 kJ/mol | −49.743±3.418 kJ/mol | −2496.688±211.449 kJ/mol | |
| −385.322±25.729 kJ/mol | −3409.484±191.462 kJ/mol | 1402.503±168.263 kJ/mol | −46.858±3.196 kJ/mol | −2439.161±177.897 kJ/mol | |
| −476.721±51.863 kJ/mol | −3210.767±347.258 kJ/mol | 1416.888±187.026 kJ/mol | −55.986±6.501 kJ/mol | −2326.586±257.206 kJ/mol | |
| −349.521±29.311 kJ/mol | −2595.898±213.434 kJ/mol | 943.357±139.722 kJ/mol | −40.623±3.674 kJ/mol | −2042.686±187.664 kJ/mol | |
| −600.270±28.395 kJ/mol | −3868.102±385.872 kJ/mol | 1952.478±206.839 kJ/mol | −68.488±3.175 kJ/mol | −2584.382±246.216 kJ/mol |
Fig. 5MM/PBSA analysis of HECT proteins bound to E2. Binding free energy decomposition at residue basis for (A) NEDD4L, (B) WWP1, (C) WWP2, (D) HECW1, and (E) HECW2 upon binding to E2UbcH5B.
Fig. 6MM/PBSA analysis of E2in complex with HECT proteins. Binding free energy decomposition at residue basis for E2UbcH5B upon binding to (A) NEDD4L, (B) WWP1, (C) WWP2, (D) HECW1, and (E) HECW2.
Fig. 7Binding cavity orientations of apo-E2 and E2-bound WWP1, WWP2, HECW1, and HECW2 proteins. Distances between Asp87 and Asp116 residues of (A) apo-E2 and E2-bound complexes with (B) NEDD4L, (C) WWP1, (D) WWP2, (E) HECW1, and (F) HECW2. NEDD4L, WWP1, WWP2, HECW1, and HECW2 structures are shown in yellow, pink, orange, green and purple ribbons, respectively, while the distance between Asp87 and Asp116 residues is shown by red dotted line.
Fig. 8Comparative distance illustration for cysteine residues of E2-bound WWP1, WWP2, HECW1, and HECW2 with respect to E2-NEDD4L. Distance between Cys85 of E2 and (A) Cys890 of WWP1, (B) Cys838 of WWP2, (C) Cys942 of NEDD4L, (D) Cys1574 of HECW1, and (E) Cys1540 of HECW2.
Fig. 9Binding analysis of E2-derived peptides in complex with NEDD4L, WWP1, WWP2, HECW1 and HECW2. Optimal docked complexes of E2 peptide-1 (His55-Phe69) with (A) NEDD4L, (B) WWP1, (C) WWP2, (D) HECW1 and (E) HECW2. E2 peptide-2 (Asn81-Ala96) in complex with (F) NEDD4L, (G) WWP1, (H) WWP2, (I) HECW1 and (J) HECW2. E2 peptide-1 (His55-Phe69) is shown in red colored atomic structure, while peptide-2 is shown in blue color. NEDD4L, WWP1, WWP2, HECW1, and HECW2 structures are shown in yellow, pink, orange, green, and purple ribbons, respectively, while their respective interacting residues are represented in ball and stick mode and labelled in black color.
Fig. 10Schematic illustration of SARS-CoV2 viral egression and spread via ESCRT complex and inhibitory mechanism of SARS-CoV2 cycle via peptide inhibitors. Left side illustrates the normal mechanism of SARS-CoV2 lifecycle. SARS-CoV2 binds to WW domain of HECT proteins via the PPXY motif embedded in its S (Spike)-protein. HECT domain binds to E2 ligase and Ub, transferring its Ub to the S-protein and the ubiquitinated S-protein then enters the cell via endocytosis. It is then recognized by ESCRT complex, which promotes viral budding or egression of the SARS-CoV2 virus causing it to spread violently. On the right side, proposed peptide inhibitors bind to the HECT domain and block the binding site of E2. E2 does not bind to the HECT domain, which in turn, does not transfer Ub to the S-protein, and ultimately, ubiquitination is abrogated. This halts the viral egression and spread of SARS-CoV2 via ESCRT complex.